Tectonic Therapeutic Files Q1 2025 10-Q

Ticker: TECX · Form: 10-Q · Filed: May 8, 2025 · CIK: 1681087

Tectonic Therapeutic, Inc. 10-Q Filing Summary
FieldDetail
CompanyTectonic Therapeutic, Inc. (TECX)
Form Type10-Q
Filed DateMay 8, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, biotech, financials, equity

Related Tickers: TECX

TL;DR

Tectonic Therapeutic (TECX) filed its Q1 2025 10-Q. Equity details updated.

AI Summary

Tectonic Therapeutic, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly known as AVROBIO, Inc., is a biotechnology firm focused on biological products. Key financial data points include details on common stock, preferred stock, and additional paid-in capital as of March 31, 2025, and prior periods.

Why It Matters

This filing provides investors with an update on Tectonic Therapeutic's financial position and equity structure as of the first quarter of 2025.

Risk Assessment

Risk Level: medium — Biotechnology companies often carry higher risk due to the nature of drug development and regulatory hurdles.

Key Numbers

  • 2025-03-31 — Reporting Date (As of this date, financial details are reported.)
  • 2024-12-31 — Prior Year End (Comparison point for financial data.)

Key Players & Entities

  • Tectonic Therapeutic, Inc. (company) — Filer
  • AVROBIO, Inc. (company) — Former company name
  • 20250331 (date) — Reporting period end date

FAQ

What is the primary business of Tectonic Therapeutic, Inc.?

Tectonic Therapeutic, Inc. is involved in Biological Products (NO DIAGNOSTIC SUBSTANCES) as indicated by its SIC code [2836].

When was Tectonic Therapeutic, Inc. formerly known as AVROBIO, Inc.?

The company was formerly known as AVROBIO, Inc. with a date of name change on 20180131.

What is the fiscal year end for Tectonic Therapeutic, Inc.?

The fiscal year end for Tectonic Therapeutic, Inc. is December 31 (1231).

What types of stock and equity are detailed in the filing?

The filing details information on Restricted Stock Units (RSUs), Preferred Stock, Convertible Preferred Stock, Restricted Stock, Employee Stock Options, and Additional Paid-In Capital.

What is the business address and phone number for Tectonic Therapeutic, Inc.?

The business address is 490 ARSENAL WAY, SUITE 210, WATERTOWN, MA 02472, and the business phone number is (339) 666-3320.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding Tectonic Therapeutic, Inc. (TECX).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.